RDF/XML JSON-LD N3/Turtle RDF/JSON

Guijarro Herráiz, Carlos carlos.guijarro@urjc.es

Especialidades Médicas y Salud Pública / Universidad Rey Juan Carlos

Actividades

Clinical trials, science and economy

  • Velasco, M.
  • Sanmartin, P.
  • Alonso, J. C.
  • Guijarro, C.;

Revista De Calidad Asistencial (p. 247-249) - 1/9/2016

10.1016/j.cali.2016.04.006 Ver en origen

  • ISSN 18871364

Comprehensive management of risk factors in peripheral vascular disease. Expert consensus

  • Barrios, V.
  • Beato, P.
  • Brotons, C.
  • Campuzano, R.
  • Merino-Torres, J.F.
  • Mostaza, J.M.
  • Plana, N.
  • Rubio, J.A.
  • Comellas, M.
... Ver más Contraer

REVISTA CLINICA ESPANOLA (p. 82-90) - 1/2/2022

Editor: Sociedad Espanola de Medicina Interna (SEMI)

10.1016/j.rce.2020.11.006 Ver en origen

  • ISSN 15781860
  • ISSN/ISBN 1578-1860

Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should be included in a basic lipid profile?

  • Velilla, TA
  • Guijarro, C
  • Ruiz, RC
  • Pinero, MR
  • Marcos, JFV
  • Perez, AP
  • Lopez, MAB
  • Lopez, AM
  • Donaire, JAG
  • Obaya, JC
  • Guerra, LC
  • Carratala, VP
  • Cabello, IE
  • Lazo, MS
  • Rodrigo, MMC
  • Prieto, JMM
  • Doblas, JJG
  • Soto, AB
... Ver más Contraer

Clinica E Investigacion En Arteriosclerosis (p. 91-100) - 17/4/2023

10.1016/j.arteri.2022.10.002

  • ISSN 15781879
  • iMarina

Consensus document of the Spanish Society of Arteriosclerosis on indications of inhibitors of PCSK9

  • Masana, Luis
  • Ascaso, Juan F.
  • Civeira, Fernando
  • Pedro-Botet, Juan
  • Valdivielso, Pedro
  • Guijarro, Carlos
  • Mostaza, Jose
  • Lopez Miranda, Jose
  • Pinto, Xavier;Soc Espanola Arteriosclerosis
... Ver más Contraer

Clinica E Investigacion En Arteriosclerosis (p. 164-165) - 1/5/2016

10.1016/j.arteri.2016.02.001 Ver en origen

  • ISSN 15781879

Consensus on objectives and action guidelines on low density lipoproteins-cholesterol control in very high risk cardiovascular patients

  • Galve, Enrique
  • Guijarro-Herraiz, Carlos
  • Masana-Marin, Luis
  • Cordero-Fort, Alberto;

Clinica E Investigacion En Arteriosclerosis (p. 31-42) - 1/2/2016

10.1016/j.arteri.7015.09.002 Ver en origen

  • ISSN 15781879

Delphi-based recommendations for the management of cardiovascular comorbidities in patients with psoriatic arthritis and moderate-to-severe psoriasis

  • Montejo, Pedro Zarco
  • Almodovar Gonzalez, Raquel
  • De Higes-Martinez, Eva
  • Jose Gorgojo-Martinez, Juan
  • Guijarro Herraiz, Carlos
  • Lopez Navas, Maria Jesus
  • Palacios, David
  • Pelaez Alvarez, Jose Carlos
  • Ruiz Genao, Diana
  • Piedrafita, Blanca
  • Gomez, Susana
  • Falkenbach, Erica
  • Rebollo Laserna, Francisco Jose
  • Lopez Estebaranz, Jose Luis;
... Ver más Contraer

Rheumatology International (p. 969-981) - 1/6/2020

10.1007/s00296-020-04573-w Ver en origen

  • ISSN 1437160X

Device Closure for Stroke with Patent Foramen Ovale

  • Guijarro, Carlos;

New England Journal Of Medicine (p. 2322-2323) - 14/6/2012

  • ISSN 15334406
  • iMarina

Diabetes and the Risk of Long-term Post-COVID Symptoms

  • Fernandez-de-Las-Penas, Cesar
  • Guijarro, Carlos
  • Torres-Macho, Juan
  • Velasco-Arribas, Maria
  • Plaza-Canteli, Susana
  • Hernandez-Barrera, Valentin
  • Arias-Navalon, Jose A.;
... Ver más Contraer

Diabetes (p. 2917-2921) - 1/12/2021

10.2337/db21-0329 Ver en origen

  • ISSN 00121797

Diagnostic neoplasms in internal medicine ward: determining characteristics and factors to define the diagnostic-therapeutic efforts

  • Perez Rueda, M.
  • Herreros, B.
  • Guijarro, C.
  • Comeche, B.;

Revista Clinica Espanola (p. 592-593) - 1/12/2010

10.1016/j.rce.2010.05.014 Ver en origen

  • ISSN 00142565

Differences in the use of health resources by Spanish and immigrant HIV-infected patients

  • Velasco, Maria
  • Castilla, Virgilio
  • Guijarro, Carlos
  • Moreno, Leonor
  • Barba, Raquel
  • Losa, Juan E.;

Enfermedades Infecciosas Y Microbiologia Clinica (p. 458-462) - 1/10/2012

10.1016/j.eimc.2012.01.007 Ver en origen

  • ISSN 0213005X

Este/a investigador/a no tiene libros.

Este/a investigador/a no tiene capítulos de libro.

A combination of alleles in TRAIL, TRAILR-1 and TRAILR-2 genes is associated with MS susceptibility

  • Lopez-Gomez, C.
  • Fernandez, O.
  • Garcia-Leon, J. A.
  • Pinto-Medel, M. J.
  • Oliver-Martos, B.
  • Ortega-Pinazo, J.
  • Orpez-Zafra, T.
  • Arnaiz-Urrutia, C.
  • Guijarro-Castro, C.
  • Benito-Leon, J.
  • Prat, I.
  • Varade, J.
  • Alvarez-Lafuente, R.
  • Urcelay, E.
  • Leyva, L.;REEM
... Ver más Contraer

Multiple Sclerosis Journal (p. S111-S111) - 1/10/2011

  • ISSN 13524585
  • iMarina

ASSOCIATION BETWEEN LOW HDL-C AND FAMILY HISTORY OF PREMATURE CORONARY HEART DISEASE IN SPANISH STATIN-TREATED PATIENTS. THE DYSLIPIDEMIA INTERNATIONAL STUDY (DYSIS-SPAIN)

  • Millan, J.
  • Gonzalez-Juanatey, J. R.
  • Guijarro, C.
  • Alegria, E.
  • Lozano, J. V.
  • Gonzalez-Timon, B.
  • Vitale, G.;
... Ver más Contraer

Atherosclerosis Supplements (p. 153-153) - 10/6/2010

10.1016/s1567-5688(10)70715-7 Ver en origen

  • ISSN 15675688

Ankle brachial index (ABI) is the single most relevant independent prognostic marker for recurrent vascular events. 5 years of follow up of the AIRVAG cohort

  • Lopez-Bescos, Lorenzo
  • Herreros, Benjamin
  • Huelmos, Ana I.
  • Puras, Enrique
  • Sanchez, Carmen
  • Gonzalez-Anglada, Isabel
  • Guijarro, Carlos;AIRVAG Invest
... Ver más Contraer

Circulation (p. 747-748) - 16/10/2007

  • ISSN 00097322
  • iMarina

Ankle-brachial index is a better predictor than C-reactive protein of new ischemic events in patients with clinical atherosclerosis. The AIRVAG cohort

  • Guijarro, C
  • Huelmos, AI
  • Belinchon, JC
  • Jimenez, J
  • Lujan, S
  • Puras, E
  • Sanchez, C
  • Cava, F
  • Lopez-Bescos, L;AIRVAG investigators
... Ver más Contraer

Circulation (p. 437-438) - 26/10/2004

  • ISSN 00097322
  • iMarina

Atorvastatin abolishes macrophage infiltration, and reduces neointimal formation and MCP-1 expression in a rabbit model of atherosclerosis. Role of nuclear factor kappa B

  • HernandezPresa, MA
  • Bustos, C
  • Ortego, M
  • Tunon, J
  • Guijarro, C
  • Diaz, C
  • Hernandez, G
  • Egido, J;
... Ver más Contraer

Circulation (p. 1621-1621) - 21/10/1997

  • ISSN 00097322
  • iMarina

Atorvastatin inhibition of NF-kappa B activation in vascular smooth muscle cells is mediated by protein isoprenylation blockade

  • Ortego, M
  • Bustos, C
  • HernandezPresa, M
  • Guijarro, C
  • Tunon, J
  • Egido, J;

Atherosclerosis (p. 131-131) - 1/10/1997

10.1016/s0021-9150(97)88709-6 Ver en origen

  • ISSN 00219150

Atorvastatin reduces lesion size and macrophage content in a rabbit model of atherosclerosis, and attenuates NF kappa B activation and MCP-1 expression in cultured VSMC.

  • Bustos, C
  • HernandezPresa, MA
  • Ortego, M
  • Tunon, J
  • Ortega, L
  • Guijarro, C
  • Diaz, C
  • Hernandez, G
  • Egido, J;
... Ver más Contraer

Atherosclerosis (p. 23-23) - 1/5/1997

  • ISSN 00219150
  • iMarina

BEYOND FARNESYL - ROLE OF GERANYLGERANYL(GG) IN HUMAN MESANGIAL CELL (HMC) DNA-SYNTHESIS STIMULATED BY PDGF

  • MASSY, ZA
  • KASISKE, BL
  • GUIJARRO, C
  • KIM, Y
  • KEANE, WF
  • ODONNELL, MP;

Journal Of The American Society Of Nephrology (p. 800-800) - 1/9/1995

  • ISSN 10466673
  • iMarina

CHARACTERISTICS OF PATIENTS WITH HIGH CLDL PLUS LOW CHDL AND/OR HIGH TG IN SPAIN. THE DYSLIPIDEMIA INTERNATIONAL STUDY (DYSIS-SPAIN)

  • Millan, J.
  • Gonzalez-Juanatey, J. R.
  • Alegria, E.
  • Guijarro, C.
  • Lozano, J. V.
  • Gonzalez-Timon, B.
  • Vitale, G.;
... Ver más Contraer

Atherosclerosis Supplements (p. 161-161) - 10/6/2010

10.1016/s1567-5688(10)70758-3 Ver en origen

  • ISSN 15675688

CHRONIC RENAL-ALLOGRAFT REJECTION AND CLINICAL-TRIAL DESIGN

  • KASISKE, BL
  • MASSY, ZA
  • GUIJARRO, C
  • MA, JZ;

Kidney International (p. S116-S119) - 1/12/1995

  • ISSN 00852538
  • iMarina

Este/a investigador/a no tiene documentos de trabajo.

Este/a investigador/a no tiene informes técnicos.

Este/a investigador/a no tiene proyectos de investigación.

Este/a investigador/a no tiene tesis dirigidas.

Este/a investigador/a no tiene patentes o licencias de software.

Última actualización de los datos: 24/04/24 13:20